Research

Dr. Vanesa Pytel, the new Secretary of the SEN Neuroimaging Study Group

25/01/2023
Neurologist Vanesa Pytel, a member of the Ace Alzheimer Center Barcelona team, has been appointed secretary of the Neuroimaging Study Group of the Spanish Society of Neurology (SEN).

A goodbye to Dr. Manuel Sarasa, a leader in Alzheimer's research

27/05/2020Research
Dr. Sarasa was the scientific founder of the biotech company Araclon Biotech, has died after a long illness. Dr. Mercè Boada, medical director at Fundació ACE, wanted to remember with a sense and personal communication in the...

The Clinical Trials Unit restarts face-to-face activity

26/05/2020Research
The Fundació ACE's Clinical Trials Unit once again receives participants from active studies in person. The recovery of the activity strictly complies with all safety and prevention criteria.

Coronavirus marks a before and after in clinical trials

21/05/2020Research
Dr. Mercè Boada has stated that the coronavirus pandemic has marked a before and after in the field of clinical trials in particular and in the way of understanding medicine in general. 

Carla Abdelnour, internationally recognized in the field of clinical trials

27/04/2020Research
Carla Abdelnour, a neurologist at Fundació ACE, has been elected representative of the Executive Committee of the Area of Clinical Trials Advances and Methods of the International Society for the Advancement of Alzheimer's Research and Treatment (ISTAART)

The relationship between retinal thickness and dementia: objective of the latest Fundació ACE study

22/04/2020Research
The prestigious journal Alzheimer's Research & Therapy has published an article by Fundació ACE Research Unit team on the association between the thickness of the retina and the accumulation of the protein β-amyloid in the brain.